Glenmark
Glenmark's Favipiravir shows positive results in Phase-3 COVID-19 trial
The results also demonstrated 40 per cent faster achievement of 'clinical cure' defined as the physician's assessment of normalization
Glenmark shares fall as DGCI sends notice on overpricing of COVID-19 drug FabiFlu
The cost proposed by Glenmark for FabiFlu is not in the interest of the poor, lower middle class and middle class people of India, DCGI said
India's Glenmark to conduct trials for potential Covid19 drug
Shares of Mumbai-based Glenmark Pharmaceuticals, which rose as much as 8.9% to 359 rupees ($4.78), was trading up 5.9%
Swadesh Mondal, Srihari Nataraj make giant strides to break national records
Mondal elevated the benchmark of excellence earlier by winning his third gold medal with a national record breaking time of 02:10.93.
Pharma shows growth despite pre-GST fears
The organised pharma retail market continued the trend of steady upward rise this year despite pre-GST fears.
1 of 1